The role of inflammation in epileptogenesis

Laboratory Experimental Neurology, Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Via G. La Masa 19, 20156 Milano, Italy.
Neuropharmacology (Impact Factor: 5.11). 04/2012; 69. DOI: 10.1016/j.neuropharm.2012.04.004
Source: PubMed


One compelling challenge in the therapy of epilepsy is to develop anti-epileptogenic drugs with an impact on the disease progression. The search for novel targets has focused recently on brain inflammation since this phenomenon appears to be an integral part of the diseased hyperexcitable brain tissue from which spontaneous and recurrent seizures originate. Although the contribution of specific proinflammatory pathways to the mechanism of ictogenesis in epileptic tissue has been demonstrated in experimental models, the role of these pathways in epileptogenesis is still under evaluation. We review the evidence conceptually supporting the involvement of brain inflammation and the associated blood-brain barrier damage in epileptogenesis, and describe the available pharmacological evidence where post-injury intervention with anti-inflammatory drugs has been attempted. Our review will focus on three main inflammatory pathways, namely the IL-1 receptor/Toll-like receptor signaling, COX-2 and the TGF-β signaling. The mechanisms underlying neuronal-glia network dysfunctions induced by brain inflammation are also discussed, highlighting novel neuromodulatory effects of classical inflammatory mediators such as cytokines and prostaglandins. The increase in knowledge about a role of inflammation in disease progression, may prompt the use of specific anti-inflammatory drugs for developing disease-modifying treatments. This article is part of a Special issue entitled 'Epilepsy'.

Download full-text


Available from: Alon Friedman, Mar 16, 2014
    • "a substantial role in the seizure process, particularly IL-1, TNF-a and IL-6 (Galic et al., 2012; Li et al., 2011; Vezzani et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: TsTX-I, isolated from Tityus serrulatus scorpion venom, causes epileptic-like discharges when injected into the central nervous system. The involvement of excitatory amino acids and cytokines in this activity was investigated. Our results have demonstrated that TsTX-I increases the release of IFN-γ but does not alter the intracerebral concentration of the excitatory amino acids in rats. Thus, this cytokine seems to be more important in the convulsive process than glutamate. Copyright © 2015. Published by Elsevier Ltd.
    Toxicon 07/2015; 103. DOI:10.1016/j.toxicon.2015.07.006 · 2.49 Impact Factor
  • Source
    • "IL-1R1, TNF-a R1, TLR4, EP receptor subtypes) are not mere by-stander phenomena of the diseased tissue, but significantly contribute to either seizure generation or cell loss, or both (Vezzani et al., 2011a; Vezzani et al., 2013; Rojas et al., 2014). Accordingly, inhibition of cytokine or prostaglandin biosynthesis, or blockade of their receptors, significantly reduces seizures and affords neuroprotection (Vezzani et al., 2013). Anti-epileptogenic effects of some anti-inflammatory treatments have been also demonstrated (Ravizza et al., 2011; Kwon et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The proteasome is the core of the ubiquitin proteasome system and is involved in synaptic protein metabolism. The incorporation of three inducible immuno-subunits into the proteasome results in the generation of the so-called immunoproteasome, which is endowed of pathophysiological functions related to immunity and inflammation. In healthy human brain, the expression of the key catalytic β5i subunit of the immunoproteasome is almost absent, while it is induced in the epileptogenic foci surgically resected from patients with pharmaco-resistant seizures, including temporal lobe epilepsy. We show here that the β5i immuno-subunit is induced in experimental epilepsy, and its selective pharmacological inhibition significantly prevents, or delays, 4-aminopyridine-induced seizure-like events in acute rat hippocampal/entorhinal cortex slices. These effects are stronger in slices from epileptic vs normal rats, likely due to the more prominent β5i subunit expression in neurons and glia cells of diseased tissue. β5i subunit is transcriptionally induced in epileptogenic tissue likely by Toll-like receptor 4 signaling activation, and independently on promoter methylation. The recent availability of selective β5i subunit inhibitors opens up novel therapeutic opportunities for seizure inhibition in drug-resistant epilepsies. Copyright © 2015 Elsevier Inc. All rights reserved.
    Brain Behavior and Immunity 06/2015; 49. DOI:10.1016/j.bbi.2015.05.007 · 5.89 Impact Factor
  • Source
    • "One possible explanation is that early intervention might alter the mechanisms involved in epileptogenesis; e.g., by reducing the disruption of circuits that is required for the development of epilepsy. In contrast, more recent data suggest that the roles of inflammation and dysfunction of the blood brain barrier (BBB) might be determinants of epilepsy in cerebrovascular disease, and we might hypothesize that these alterations would be less important in patients with sooner craniectomies (Marchi et al., 2012; Vezzani et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients with malignant middle cerebral artery (MCA) infarctions who have undergone craniectomy are susceptible to the development of vascular epilepsy. Our objective was to study the factors that might influence the occurrence of seizures in this group of patients. All patients who developed malignant MCA infarction and had undergone decompressive craniectomy in our center between November 2002 and January 2014 were evaluated. In the subsequent follow-up, we evaluated the clinical outcomes and attempted to identify the factors that were related to the occurrence of seizures. We evaluated a total of 80 patients. The median time at which the craniectomy was performed was 40.5h after the stroke. Seizures occurred in 47.5% of all patients. The mortality rate within the first week was 16%, and of those who survived 53.7% developed seizures; 9% of these seizures were acute symptomatic, and 44.8% were remote. The median onset of remote seizures was seven months, and the majority of these were motor seizures with generalization. Notably, the patients with seizures exhibited longer delays from stroke to craniectomy, greater involvements of the temporal lobe and a higher rate of post-craniectomy recanalization of the occluded artery. Regarding the timing of the surgeries, a significantly greater proportion of those who underwent surgery more than 42h after the stroke developed epilepsy (p=0.004). Logistic regression revealed that only prolonged delay (>42h) independently predicted the development of epilepsy (OR 5.166; IC 95% 1.451-18.389; p=0.011). More than half of patients with malignant MCA infarcts who underwent decompressive craniectomy developed epilepsy. The occurrence of seizures in these patients was related to the delay to the performance of the craniectomy. Copyright © 2015 Elsevier B.V. All rights reserved.
    Epilepsy Research 03/2015; 112. DOI:10.1016/j.eplepsyres.2015.02.016 · 2.02 Impact Factor
Show more